Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents |
Son, Jang-Won
(Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine)
Kim, Ung (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) Park, Jong-Seon (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) Kim, Young-Jo (Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center) Jang, Jae-Sik (Division of Cardiology, Department of Internal Medicine, Inje University Busan Paik Hospital) Yang, Tae-Hyun (Division of Cardiology, Department of Internal Medicine, Inje University Busan Paik Hospital) Kim, Dong-Soo (Division of Cardiology, Department of Internal Medicine, Inje University Busan Paik Hospital) Kim, Dong-Kie (Division of Cardiology, Department of Internal Medicine, Inje University Haeundae Paik Hospital) Seol, Sang-Hoon (Division of Cardiology, Department of Internal Medicine, Inje University Haeundae Paik Hospital) Kim, Doo-Il (Division of Cardiology, Department of Internal Medicine, Inje University Haeundae Paik Hospital) Nam, Chang-Wook (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) Hur, Seung-Ho (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) Kim, Kwon-Bae (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Medical Center) |
1 | Turco MA, Ormiston JA, Popma JJ, et al. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberte stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv 2008;1:699-709. DOI ScienceOn |
2 | Kim U, Seol SH, Kim DI, et al. Clinical outcomes and the risk factors of coronary artery aneurysms that developed after drug-eluting stent implantation. Circ J 2011;75:861-867. DOI ScienceOn |
3 | Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351. DOI ScienceOn |
4 | D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med 1998;17:2265-2281. DOI ScienceOn |
5 | Halkin A, Stone GW. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials. J Interv Cardiol 2004;17:271-282. DOI ScienceOn |
6 | Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxeleluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-1113. DOI ScienceOn |
7 | Kitahara H, Kobayashi Y, Yamaguchi M, et al. Damage to polymer of paclitaxel-eluting stent. Circ J 2008;72:1907-1908. DOI ScienceOn |
8 | Grube E, Silber S, Hauptmann KE, et al. TAXUS I: sixand twelve-month results from a randomized, doubleblind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42. DOI ScienceOn |
9 | Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxeleluting TAXUS stent: the TAXUS-IV trial. Circulation 2004;109:1942-1947. DOI ScienceOn |
10 | Schwalm JD, Ahmad M, Velianou JL, Pericak D, Natarajan MK. Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience. Can J Cardiol 2010;26:e40-e44. DOI ScienceOn |
11 | Rogers CD. Optimal stent design for drug delivery. Rev Cardiovasc Med 2004;5 Suppl 2:S9-S15. DOI ScienceOn |
12 | Briguori C, Sarais C, Pagnotta P, et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol 2002;40:403-409. DOI ScienceOn |
13 | Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-2821. DOI ScienceOn |
14 | Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780. DOI ScienceOn |
15 | Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323. DOI ScienceOn |
16 | Turco MA, Ormiston JA, Popma JJ, et al. Polymerbased, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial. J Am Coll Cardiol 2007;49:1676-1683. DOI ScienceOn |
17 | Hausleiter J, Kastrati A, Mehilli J, et al. Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial. Am Heart J 2003;146:882-886. DOI ScienceOn |
18 | Schofer J, Schluter M, Gershlick AH, et al. Sirolimuseluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: doubleblind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099. DOI ScienceOn |
19 | Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderaterelease polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003;108:788-794. DOI ScienceOn |
20 | Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231. DOI ScienceOn |
![]() |